EMBLEM™ MRI S-ICD System
Subcutaneous Implantable Defibrillator
S-ICD Clinical Data
S-ICD is Guideline Recommended
UNTOUCHED Acute Outcomes
The incidence of inappropriate shocks in primary prevention, LVEF ≤ 35% patients will be non-inferior to the rate in transvenous ICD patients with similar programming observed in MADIT-RIT Arms B and C.
- Follow-up for 18 months
- Device programming with a conditional zone of 200 bpm and a shock zone of 250 bpm
- Primary endpoint of inappropriate shock-free rate at 18 months
- Secondary endpoints of all cause shock-free rate at 18 months and system and procedure complications at 30 days
Conversion efficacy and complication-free rates remain high, consistent with historical S-ICD studies.
UNTOUCHED Chronic Outcomes
TV-ICD Lead Complications in the Real World
Analysis of MADIT RIT Data10
A new analysis of data from MADIT RIT demonstrates patients are more likely to develop complications from transvenous leads than they are to benefit from ATP.
- There is a statistically significant reduction in ATP with contemporary programming, suggesting that many VTs are self-terminating and earlier interventions may lead to an overestimation of the value of ATP.
- Despite the use of significantly more ATP in the conventional programming arm of MADIT RIT, there was no reduction in the final shock rate when compared to the contemporary programming arms.
SMART Pass Significantly Reduces IAS
PRAETORIAN: S-ICD vs. TV-ICD
PRAETORIAN Study Design
Clinical Data Resources
Training & Education
Explore continuing education courses, best practices modules and other training and resources for S-ICD.
See how S-ICD helps protect patients at risk for sudden cardiac death while also eliminating the risk of TV-ICD lead complications.
Learn about advancements in the S-ICD implant procedure, including the 2-incision and intermuscular implant techniques.
- Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, et al., 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death, Heart Rhythm (2017), doi: 10.1016/j.hrthm.2017.10.036.
- Polyzos, KA, Konstantelias, AA, and Falagas, ME, Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace, 2015. 17(5): p. 767-777.
- Greenspon, AJ, Patel, JD, Lau, E, et al., 16-Year Trends in the Infection Burden for Pacemakers and Implantable Cardioverter-Defibrillators in the United States. Journal of the American College of Cardiology, 2011. 58(10): p. 1001-1006.
- Friedman, DJ, Parzynski, CS, Varosy, PD, et al., Trends and In-Hospital Outcomes Associated With Adoption of the Subcutaneous Implantable Cardioverter Defibrillator in the United States. JAMA Cardiol, 2016. 1(8): p. 900-911.
- Gasparini, M, Lunati, MG, Proclemer, A, et al., Long Detection Programming in Single-Chamber Defibrillators Reduces Unnecessary Therapies and Mortality. JACC: Clinical Electrophysiology, 2017.
- LATITUDE data on file. Boston Scientific 2017.
- Kusumoto, FM, Schoenfeld, MH, Wilkoff, BL, et al., 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm, 2017.
- Boersma LV et al. Heart Rhythm. 2019;16(11):1636-1644 (graphical abstract; 10.1016/j.hrthm.2019.04.048
- Koneru, JN, Jones, PW, Hammill, EF, Wold, N, and Ellenbogen, KA, Risk Factors and Temporal Trends of Complications Associated With Transvenous Implantable Cardiac Defibrillator Leads. J Am Heart Assoc, 2018. 7(10).
- Schuger, et al. Avoiding Unnecessary Therapy for Ventricular Arrhythmias ≥ 200 bpm: Results from MADIT-RIT. S-PO03 at HRS 2019, San Francisco, CA.
- Theuns, et al. Evaluation of a Novel Algorithm Designed to Reduce Oversensing in the S-ICD. HRS 2016; AB05-01